(PDF) Cross-Reactive Dengue Virus-Derived Monoclonal

Cross-Reactive Dengue Virus-Derived Monoclonal Antibodies to Zika Virus Envelope Protein: Panacea or Pandora’s Box?

BMC Infectious Diseases - United Kingdom

doi 10.1186/s12879-018-3572-0

Full Text

Abstract

Available in full text

Categories

Infectious Diseases

Date

December 1, 2018

Authors

Shannon A. Gunawardana

Publisher

Springer Science and Business Media LLC

Related search

Human Antibody Responses After Dengue Virus Infection Are Highly Cross-Reactive to Zika Virus

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

English

Development of Envelope Protein Antigens to Serologically Differentiate Zika From Dengue Virus Infection

Journal of Clinical Microbiology

English

Limited Cross-Reactivity of Mouse Monoclonal Antibodies Against Dengue Virus Capsid Protein Among Four Serotypes

Biologics: Targets and Therapy

Gastroenterology

English

Envelope Protein Glycosylation Mediates Zika Virus Pathogenesis

Journal of Virology

English

Human Monoclonal Antibodies Potently Neutralize Zika Virus and Select for Escape Mutations on the Lateral Ridge of the Envelope Protein

Journal of Virology

English

Cross-Reactive Monoclonal Antibodies to Multiple HIV-1 Subtype and SIVcpz Envelope Glycoproteins

English

Zika Virus Activates De Novo and Cross-Reactive Memory B Cell Responses in Dengue-Experienced Donors

Science immunology

English

Adjuvant-Mediated Epitope Specificity and Enhanced Neutralizing Activity of Antibodies Targeting Dengue Virus Envelope Protein

Frontiers in Immunology

English

Author Correction: Human Antibodies to the Dengue Virus E-Dimer Epitope Have Therapeutic Activity Against Zika Virus Infection

Nature Immunology

English